A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 6448
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : CR
Long Form : complete remission
No. Year Title Co-occurring Abbreviation
2020 Allogeneic stem cell transplantation improves survival in relapsed Hodgkin lymphoma patients achieving complete remission after salvage treatment. allo-SCT, cHL, HID, MRD, NRM, PFS, PR, R/R, RR, S/PD, URD
2020 Autologous hematopoietic cell transplantation for acute myeloid leukemia in adults: 25years of experience in Japan. AML, APL, HCT
2020 Clinical heterogeneity under induction with different dosages of cytarabine in core binding factor acute myeloid leukaemia. AML, CBF, LFS, TRM
2020 Contextualizing the Use of Moxetumomab Pasudotox in the Treatment of Relapsed or Refractory Hairy Cell Leukemia. BTK, CRs, HCL, Moxe, MRD
2020 Epigenetic modifier gene mutations-positive AML patients with intermediate-risk karyotypes benefit from decitabine with CAG regimen. allo-HSCT, EMMs, HMAs, IR-AML, ORR
2020 Five-year results of the BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma. ASCT, BEGEV, cHL, ITT, OS, PFS, R/R
2020 Hypereosinophilia (HE) in acute myeloid leukemia (AML) with normal karyotype: A report of two cases. AML, FLAG, G-CSF, HE, HSCT, IA, NK-AML
2020 Immune profiling in diffuse large B-cell lymphoma and mantle cell lymphoma patients treated with autologous hematopoietic cell transplant. AHCT, B-NHL, OS, PFS
2020 JAK1/2 pathway inhibition suppresses M2 polarization and overcomes resistance of myeloma to lenalidomide by reducing TRIB1, MUC1, CD44, CXCL12, and CXCR4 expression. BM, JAKs, MM, PD, RUX, TRIB1
10  2020 Late Events after Treatment with CD19-Targeted Chimeric Antigen Receptor Modified T Cells. CAR-T cell, ICU, IVIG, MDS
11  2020 Nilotinib treatment induced large granular lymphocyte expansion and maintenance of longitudinal remission in a Philadelphia chromosome-positive acute lymphoblastic leukemia. ALL, LGLs, Ph
12  2020 Obinutuzumab and miniCHOP for unfit patients with diffuse large B-cell lymphoma. A phase II study by Fondazione Italiana Linfomi. CI, DLBCL, PFS and OS, sCGA
13  2020 Obinutuzumab and venetoclax induced complete remission in a patient with ibrutinib-resistant non-nodal leukemic mantle cell lymphoma. ---
14  2020 Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation. EBV-CTLs, EBV-PTLD, HCT, PR
15  2020 Outcomes of treatment with dose-adjusted EPOCH-R or R-CHOP in primary mediastinal large B-cell lymphoma. auto-HSCT, ORR, OS, PFS, PMBCL
16  2020 Overshoot of FVIII activity in patients with acquired hemophilia A who achieve complete remission. AHA, FVIII
17  2020 Perilesional Resection of Glioblastoma Is Independently Associated With Improved Outcomes. ANOVA, GBM
18  2020 Phase I Clinical Trial of Selinexor in Combination with Daunorubicin and Cytarabine in Previously Untreated Poor-Risk Acute Myeloid Leukemia. ---
19  2020 Potentiality of Protein phosphatase Mg2+ /Mn2+ dependent 1D as a biomarker for predicting prognosis in acute myeloid leukemia patients. AML, EFS, OS, PPM1D
20  2020 Recent drug approvals for newly diagnosed acute myeloid leukemia: gifts or a Trojan horse? EMA, FDA, GO
21  2020 Sorafenib and omacetaxine mepesuccinate as a safe and effective treatment for acute myeloid leukemia carrying internal tandem duplication of Fms-like tyrosine kinase 3. AML, CRi, FLT3, HSCT, LFS, NPM1, OME, OS, R/R, SOME, VAF
22  2020 Spinal cord atypical teratoid/rhabdoid tumors in children: Clinical, genetic, and outcome characteristics in a representative European cohort. PD, spATRT
23  2020 The Association of Circulating T Follicular Helper Cells and Regulatory Cells with Acute Myeloid Leukemia Patients. AML, cTfh, cTfr
24  2020 The prognosis predictive value of FMS-like tyrosine kinase 3-internal tandem duplications mutant allelic ratio (FLT3-ITD MR) in patients with acute myeloid leukemia detected by GeneScan. AML, FLT3-ITD MR, OS, wt
25  2020 The prognostic relevance and expression of progranulin in adult patients with acute myeloid leukemia. AML, HC, OS, PGRN, RFS
26  2020 The Role of Anthracyclines in Acute Myeloid Leukemia Consolidation. AML, FLT3, HSCT
27  2020 Therapeutic Dose Monitoring of Busulfan Is Associated with Reduced Risk of Relapse in Non-Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell Transplantation. ASCT, BU, CI, CY, HR, NHL, NRM, OS, PFS, PK, TDM, WBD
28  2019 A Case of Granulocytic Sarcoma of the Lung in Acute Myeloid Leukemia. AML, CT
29  2019 A case of primary gastric diffuse large B-cell lymphoma occurring in chronic myeloid leukemia. CML, CP, DLBCL, NHL, PG-DLBCL
30  2019 A cohort study of immune and hematopoietic functionality changes in severe aplastic anemia patients treated with immunosuppressive therapy. IST, mDC, NR, pDC, PR, SAA, Th
31  2019 A Comparison of Azathioprine and Mycophenolate Mofetil as Adjuvant Drugs in Patients with Pemphigus: A Retrospective Cohort Study. AZA, ECP, MMF
32  2019 A Comparison of Inpatient and Outpatient-Based Chemotherapy Regimens for the Treatment of Acute Myeloid Leukaemia In The Elderly. AML, OS, PR
33  2019 A comparison of patients with acute myeloid leukemia and high-risk myelodysplastic syndrome treated on versus off study. AML, ND, RR
34  2019 A comprehensive review of adult onset spinal teratomas: analysis of factors related to outcomes and recurrences. STR
35  2019 A favorable inductive remission rate for decitabine combined with chemotherapy as a first course in <60-year-old acute myeloid leukemia patients with myelodysplasia syndrome features. AML, IA, MDS
36  2019 A Phase 1 Study of Intravenous Busulfan as a Conditioning Regimen for Multiple Myeloma. BU, MEL, MM, MTD
37  2019 A phase 1 trial of SGN-CD70A in patients with CD70-positive diffuse large B cell lymphoma and mantle cell lymphoma. ADC, AEs, DLBCL, MCL, NHL, PBD, PRs, R/R
38  2019 A Phase 1B Clinical Study of Combretastatin A1 Diphosphate (OXi4503) and Cytarabine (ARA-C) in Combination (OXA) for Patients with Relapsed or Refractory Acute Myeloid Leukemia. AEs, AML, CRi, MDS, MTD, ORR, OS, PR, R/R, SAEs
39  2019 A Phase I/II Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Ixazomib for Relapsed Refractory Acute Myeloid Leukemia. AML, MEC, R/R
40  2019 A phase II study of a modified hyper-CVAD frontline therapy for patients with adverse risk diffuse large B-cell and peripheral T-cell non-Hodgkin lymphoma. DLBCL, IPI, PTCL
41  2019 A phase II study of addition of pracinostat to a hypomethylating agent in patients with myelodysplastic syndromes who have not responded to previous hypomethylating agent therapy. HMAs, MDS, PR, SD
42  2019 A precision medicine test predicts clinical response after idarubicin and cytarabine induction therapy in AML patients. AML, CYT, IDA
43  2019 A randomized trial of three novel regimens for recurrent acute myeloid leukemia demonstrates the continuing challenge of treating this difficult disease. AML, CT, S-MEC
44  2019 A Retrospective Case Series Of High-Intensity Focused Ultrasound (HIFU) In Combination With Gemcitabine And Oxaliplatin (Gemox) On Treating Elderly Middle And Advanced Pancreatic Cancer. CBR, CBR, DCR, HIFU, ORR, OS, PFS, PR, SD
45  2019 A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL. CI, CLL, HRs, ORRs, OS, PFS, R/R, VEN
46  2019 A retrospective study of the correlation of in vitro chemosensitivity using ATP-TCA with patient clinical outcomes in acute myeloid leukemia. CI, HR
47  2019 A systematic review and meta-analysis of the efficacy and adverse events of azacitidine-plus-lenalidomide treatment for patients with acute myeloid leukemia, myelodysplastic syndromes and chronic myelomonocytic leukemia 1. AML, AZA, CI, CMML, LEN, MDS, ORR
48  2019 A-kinase interacting protein 1 might serve as a novel biomarker for worse prognosis through the interaction of chemokine (C-X-C motif) ligand 1/chemokine (C-X-C motif) ligand 2 in acute myeloid leukemia. AKIP1, AML, EFS, OS
49  2019 Aberrant Phenotype and Function of Dendritic Cells in Adult B Lineage Acute Lymphoblastic Leukemia. ALL, B-ALL, CONS, DCs, HR, mDC, MoDC, MRD, ND, pDC, SR
50  2019 Absolute Lymphocyte Count at the End of Induction as a Surrogate Marker for Minimal Residual Disease in T-cell Acute Lymphoblastic Leukemia. ALC, MRD, T-ALL
51  2019 Achieving Complete Remission of Hepatocellular Carcinoma: A Significant Predictor for Recurrence-Free Survival after Liver Transplantation. HCC, LT
52  2019 Acute myeloid leukemia patient with FLT3-ITD and NPM1 double mutation should undergo allogeneic hematopoietic stem cell transplantation in CR1 for better prognosis. allo-HSCT, AML, DFS, HL, NCCN, OS
53  2019 Acute myeloid leukemia with central diabetes insipidus. AML, CDI
54  2019 Acute promyelocytic leukemia with a cryptic insertion of RARA into TBL1XR1. APL, CBT, NGS
55  2019 ADAM28 promotes tumor growth and dissemination of acute myeloid leukemia through IGFBP-3 degradation and IGF-I-induced cell proliferation. AML, CIR
56  2019 Addition of Low-Dose Decitabine to Anti-PD-1 Antibody Camrelizumab in Relapsed/Refractory Classical Hodgkin Lymphoma. cHL, PD-1
57  2019 Adoptive cellular immunotherapy for refractory childhood cancers: a single center experience. ACI, aGVHD, OS, PFS
58  2019 Adoptive Immunotherapy for B-cell Malignancies Using CD19- Targeted Chimeric Antigen Receptor T-Cells: A Systematic Review of Efficacy and Safety. CAR-T, HR, PR
59  2019 Advanced Burkitt Lymphoma in Sub-Saharan Africa Pediatric Units: Results of the Third Prospective Multicenter Study of the Groupe Franco-Africain d'Oncologie Pediatrique. BL, GFALMB, HD-MTX, OS
60  2019 Allogeneic hematopoietic stem cell transplantation for patients with relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation. BV, IR, PFS, sALCL
61  2019 Allogeneic Hematopoietic Stem Cell Transplantation, Especially Haploidentical, May Improve Long-Term Survival for High-Risk Pediatric Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Tyrosine Kinase Inhibitor Era. ALL, allo-HSCT, CIR, EFS, MMR, OS, TKI
62  2019 Allogeneic transplantation for high-risk chronic lymphocytic leukemia-a summary of a 16-year experience. ASCT, CLL, GVHD, PR, RIC
63  2019 alpha-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by alpha-TGFbeta antibody to promote durable rejection and immunity in squamous cell carcinomas. EMT, SCC
64  2019 Analysis of Efficacy and Prognostic Factors of CLAG Treatment in Chinese Patients with Refractory or Relapsed Acute Myeloid Leukemia. AML, BM, OS, R/R
65  2019 Analysis of key clinical features for achieving complete remission in stage III and IV non-small cell lung cancer patients. NSCLC, OS
66  2019 Analysis of the clinical impact of NPM1 mutant allele burden in a large cohort of younger adult patients with acute myeloid leukaemia. NPM1MUT
67  2019 Anthracycline-based consolidation may determine outcome of post-consolidation immunotherapy in AML. AML, HDC, ICD
68  2019 Antiphospholipase 2 receptor antibody levels to predict complete spontaneous remission in primary membranous nephropathy. MN
69  2019 Anxiety and depression predict unfavorable survival in acute myeloid leukemia patients. AML, EFS, HADS, HCs, OS
70  2019 Appropriate radiation dose for symptomatic relief and local control in patients with adult T cell leukemia/lymphoma. ATL, PR, RT
71  2019 Association between increased mutation rates in DNMT3A and FLT3-ITD and poor prognosis of patients with acute myeloid leukemia. AML, DNMT3A, FLT3-ITD, OS, WBCs
72  2019 Azacitidine maintenance after intensive chemotherapy improves DFS in older AML patients. AML, CRi, DFS, OS
73  2019 BCL3 Expression Is a Potential Prognostic and Predictive Biomarker in Acute Myeloid Leukemia of FAB Subtype M2. AML, FAB
74  2019 Blinatumomab for Acute Lymphoblastic Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. ALL, allo-HSCT, CRh, MRD, R/R
75  2019 Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT. AML, BM, HSCT, IR
76  2019 Bone Marrow Mast Cell Antibody-Targetable Cell Surface Protein Expression Profiles in Systemic Mastocytosis. ASM, BMMC, MCL, SM, WDSM
77  2019 Bortezomib-based induction followed by stem cell transplantation in light chain amyloidosis: results of the multicenter HOVON 104 trial. SCT, VGPR
78  2019 Breast myeloid sarcoma after allogeneic stem cell transplantation for acute myelomonocytic leukemia - case report. allo-SCT, AML, CD, CK7, ER, MPO, MS, PR
79  2019 CD19 and CD70 Dual-Target Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Relapsed and Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma. CAR, CRES, CRS, DLBCL, PCNS-DLBCL, PCNSL
80  2019 CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia. ---
81  2019 CD34+CD38- leukemic stem cell frequency to predict outcome in acute myeloid leukemia. AML, CIR, HR, LSC, OS
82  2019 Clearance of Hematologic Malignancies by Allogeneic Cytokine-Induced Killer Cell or Donor Lymphocyte Infusions. CIK, DLI, HSCT
83  2019 Clinical Characteristics And Outcome Of Biphenotypic Acute Leukemia: 10 Case Reports And Literature Review. BAL, HSCT, MPAL, RT-PCR
84  2019 Clinical characteristics and prognostic factors of primary extranodal classical Hodgkin lymphoma: a retrospective study. LDH, ORR, OS, PE-cHL, PFS, PLT
85  2019 Clinical efficacy and safety of rituximab in lupus nephritis. LN, RTX, TR
86  2019 Clinical efficacy of cisplatin, dexamethasone, gemcitabine and pegaspargase (DDGP) in the initial treatment of advanced stage (stage III-IV) extranodal NK/T-cell lymphoma, and its correlation with Epstein-Barr virus. DCR, DDGP, EBV, ORR, OS, PD, PFS, PR, SD
87  2019 Clinical features and treatment outcome of elderly multiple myeloma patients with impaired renal function. MM, RI
88  2019 Clinical features, treatment and outcomes of colorectal mucosa-associated lymphoid tissue (MALT) lymphoma: literature reviews published in English between 1993 and 2017. MALT
89  2019 Clinical outcomes and effects of treatment in older patients with idiopathic membranous nephropathy. CI, ESRD, MN, OR
90  2019 Clinicians' Perspectives on Cure in Adult Patients withAcute Lymphoblastic Leukemia with Minimal Residual Disease: A Delphi Study. BCP-ALL, MRD, RFS
91  2019 Combination immunosuppressant therapy and lupus nephritis outcome: a hospital-based study. CI, ESRD, HR, HR, LN, OR, PR
92  2019 Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma. DW-MRI, FLs, MM, MRD, PET, PFS
93  2019 Comparison of efficacy of HCAG and FLAG re-induction chemotherapy in acute myeloid leukemia patients of low- and intermediate-risk groups. AML, PFS
94  2019 Comparisons of therapeutic outcomes in patients with nonampullary duodenal neuroendocrine tumors (NADNETs): A multicenter retrospective study. DNETs, NADNETs
95  2019 Complications and outcomes in diffuse large B-cell lymphoma with gastric lesions treated with R-CHOP. DLBCL, DLBCL-GL, R-IPI
96  2019 Comprehensive prognostic scoring systems could improve the prognosis of adult acute myeloid leukemia patients. AML, CPSS, LDH, OS, RFS
97  2019 Consolidation with 90Y ibritumomab tiuxetan radioimmunotherapy in mantle cell lymphoma patients ineligible for high dose therapy: results of the phase II multicentre Polish Lymphoma Research Group trial, after 8-year long follow-up. ---
98  2019 Continuous B-cell depletion in frequently relapsing, steroid-dependent and steroid-resistant nephrotic syndrome. FR, FSGS, IQR, MCD, PR, SD, SR, UPCR
99  2019 Cord blood transplantation is associated with good outcomes in secondary Acute Myeloid Leukaemia in first remission. CBT, EBMT, GVHD, sAML
100  2019 Cost Effectiveness of Midostaurin in the Treatment of Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia in the United States. AML, ICER, LY, QALY, SCT